Literature DB >> 34246791

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer: A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC).

Christian Rolfo1, Philip Mack1, Giorgio V Scagliotti2, Charu Aggarwal3, Maria E Arcila4, Fabrice Barlesi5, Trever Bivona6, Maximilian Diehn7, Caroline Dive8, Rafal Dziadziuszko9, Natasha Leighl10, Umberto Malapelle11, Tony Mok12, Nir Peled13, Luis E Raez14, Lecia Sequist15, Lynette Sholl16, Charles Swanton17, Chris Abbosh18, Daniel Tan19, Heather Wakelee20, Ignacio Wistuba21, Rebecca Bunn22, Janet Freeman-Daily23, Murry Wynes24, Chandra Belani25, Tetsuya Mitsudomi26, David Gandara27.   

Abstract

Entities:  

Keywords:  IASLC; NSCLC; ctDNA; immunotherapy.; liquid biopsy; oncogene addicted

Year:  2021        PMID： 34246791     DOI： 10.1016/j.jtho.2021.06.017

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  43 in total

1.  Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.

Authors:  Viswam S Nair; Angela Bik-Yu Hui; Pierre P Massion; Jacob J Chabon; Mohammad S Esfahani; Henning Stehr; Barzin Y Nabet; Li Zhou; Aadel A Chaudhuri; Jalen Benson; Kelsey Ayers; Harmeet Bedi; Meghan Ramsey; Ryan Van Wert; Sanja Antic; Natalie Lui; Leah Backhus; Mark Berry; Arthur W Sung; Joseph B Shrager; Ash A Alizadeh; Maximilian Diehn
Journal:  Cancer Res       Date:  2022-08-16       Impact factor: 13.312

2.  Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced Cancers.

Authors:  Mohamed A Gouda; Helen J Huang; Sarina A Piha-Paul; S Greg Call; Daniel D Karp; Siqing Fu; Aung Naing; Vivek Subbiah; Shubham Pant; Derek J Dustin; Apostolia M Tsimberidou; David S Hong; Jordi Rodon; Funda Meric-Bernstam; Filip Janku
Journal:  JCO Precis Oncol       Date:  2022-07

Review 3.  Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges.

Authors:  Hiu Ting Chan; Yoon Ming Chin; Siew-Kee Low
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

4.  Liquid First Is "Solid" in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing.

Authors:  Or Sehayek; Waleed Kian; Amir Onn; Ronen Stoff; Hadas Gantz Sorotsky; Melanie Zemel; Jair Bar; Yulia Dudnik; Hovav Nechushtan; Yakir Rottenberg; Lior Soussan-Gutman; Addie Dvir; Laila C Roisman; Nir Peled
Journal:  Front Oncol       Date:  2022-06-15       Impact factor: 5.738

5.  Patient and Clinician Preferences for Genetic and Genomic Testing in Non-Small Cell Lung Cancer: A Discrete Choice Experiment.

Authors:  Simon Fifer; Robyn Ordman; Lisa Briggs; Andrea Cowley
Journal:  J Pers Med       Date:  2022-05-26

6.  Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France).

Authors:  Marius Ilié; Véronique Hofman; Christophe Bontoux; Simon Heeke; Virginie Lespinet-Fabre; Olivier Bordone; Sandra Lassalle; Salomé Lalvée; Virginie Tanga; Maryline Allegra; Myriam Salah; Doriane Bohly; Jonathan Benzaquen; Charles-Hugo Marquette; Elodie Long-Mira; Paul Hofman
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

Review 7.  Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.

Authors:  Frédérique Penault-Llorca; Keith M Kerr; Pilar Garrido; Erik Thunnissen; Elisabeth Dequeker; Nicola Normanno; Simon J Patton; Jenni Fairley; Joshua Kapp; Daniëlle de Ridder; Aleš Ryška; Holger Moch
Journal:  Virchows Arch       Date:  2022-07-20       Impact factor: 4.535

8.  Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.

Authors:  Jennifer A Fairley; Melanie H Cheetham; Simon J Patton; Etienne Rouleau; Marc Denis; Elisabeth M C Dequeker; Ed Schuuring; Kaat van Casteren; Francesca Fenizia; Nicola Normanno; Zandra C Deans
Journal:  BMC Cancer       Date:  2022-07-12       Impact factor: 4.638

9.  Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study.

Authors:  Fangfang Shen; Naixin Liang; Zaiwen Fan; Min Zhao; Jing Kang; Xifang Wang; Qun Hu; Yongping Mu; Kai Wang; Mingming Yuan; Rongrong Chen; Wei Guo; Guilan Dong; Jun Zhao; Jun Bai
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

10.  ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors.

Authors:  Wei Nie; Zhi-Jie Wang; Kai Zhang; Bing Li; Yi-Ran Cai; Feng-Cai Wen; Ding Zhang; Yue-Zong Bai; Xue-Yan Zhang; Shu-Yuan Wang; Lei Cheng; Hua Zhong; Li Liu; Jie Wang; Bao-Hui Han
Journal:  BMC Med       Date:  2022-05-05       Impact factor: 11.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.